Tune in for insightful discussions on oncology, featuring interviews with leading experts. Stay informed on cancer care, treatments, and research in a convenient audio format.
Rebecca Dent MD: First-Line T-DXd Combination Adds More Than a Year of Progression Free Survival for Patients with Advanced HER2 Positive Breast Cancer
17 mins • Jul 30, 2025
Charts
- 173Decreased by 26
- 196Increased by 0
Recent Episodes

Jul 30, 2025
Rebecca Dent MD: First-Line T-DXd Combination Adds More Than a Year of Progression Free Survival for Patients with Advanced HER2 Positive Breast Cancer
17 mins

Jul 18, 2025
Erica L. Mayer MD MPH: Adjuvant Abemaciclib: Start Low, then Dose Escalate in Early-stage HR+/HER2- Breast Cancer: TRADE Study Findings
9 mins

Jul 12, 2025
Patients with Early-Stage Non-Squamous Non-Small Cell Lung Cancer Who can Benefit from Adjuvant Chemotherapy
12 mins

Jul 3, 2025
Adjuvant Nivolumab Extends Disease-Free Survival in Patients with High-Risk Head and Neck Cancers
10 mins

Jun 30, 2025
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025
12 mins